Skip to main content
. 2019 Mar 12;234(6):830–838. doi: 10.1111/joa.12970

Table 2.

Primary serum, clones, source, titer, and antigen retrieval

Primary serum Clones Source Titer Antigen retrieval
Bcl‐2 124 Dako 1 : 200 EDTA/Tris, pH 9.0
Cleaved Caspase‐3 Polyclonal Cell Signaling 1 : 1000 Citrate buffer, pH 6.0
Survivin Polyclonal Neomarkers 1 : 350 Citrate buffer, pH 6.0
Par‐4 A‐10 Santa Cruz 1 : 700 Citrate buffer, pH 6.0
MUC1 Ma552 Novocastra 1 : 500 Citrate buffer, pH 6.0
PHLDA1 M‐20 Santa Cruz 1 : 100 Citrate buffer, pH 6.0
SPARC Polyclonal Chemicon 1 : 6000 Trilogy*
Fas EPR5700 LSBio 1 : 700 Trilogy
FasL Polyclonal LSBio 1 : 700 Trilogy
Ki‐67 30‐9 Roche Ready to use Automated protocol (Ventana, Roche)

Fas, Fas cell surface death receptor; FasL, Fas ligand; Par‐4, prostate apoptosis response‐4; PHLDA1, pleckstrin homology‐like domain family A member 1; Bcl‐2, B‐cell CLL/lymphoma 2; MUC1, mucin 1; SPARC, secreted protein acidic and cysteine‐rich.

*

Trilogy, solution that allows deparaffinisation and antigen retrieval in a one‐step procedure.